1 February 2024
MicroSalt
plc
("MicroSalt" or the
"Company")
Notice of Presentation on
Investor Meet Company
MicroSalt plc, (AIM: SALT) a company
commercialising a patented technology to produce full-flavour,
low-sodium salt for food manufacturers and consumers, is pleased to
announce that following its admission to trading on AIM this
morning, Rick Guiney (CEO) and Konrad
Dabrowski (CFO) will hold a live presentation on the Company via
the Investor Meet Company platform on 5 February 2024 at 4pm (UK
local time).
The presentation is open to all
existing and potential shareholders. Questions can be submitted
pre-event via your Investor Meet Company dashboard up until 9am the
day before the meeting or at any time during the live
presentation.
Investors can sign up to Investor
Meet Company for free and add to meet MicroSalt plc
via:
https://www.investormeetcompany.com/microsalt-plc/register
Investors who already
follow MicroSalt plc on the Investor Meet Company
platform will automatically be invited.
For more information, please
visit www.microsaltinc.co,
follow on twitter @microSaltPLC or contact:
MicroSalt
plc
|
Via Flagstaff PR
|
Rick Guiney, CEO
|
|
|
|
Zeus (Nominated
Adviser and Broker)
|
+44 (0)20 3829 5000
|
David Foreman / James Edis (Investment
Banking)
|
|
Dom King (Corporate Broking), Rupert Woolfenden
(Sales)
|
|
|
|
Flagstaff
PR (Financial PR)
|
+44 (0)20 7129 1474
|
Tim Thompson / Alison Allfrey / Anna
Probert
microsalt@flagstaffcomms.com
|
|
Notes to Editors
MicroSalt® produces a patented
full-flavour, low-sodium salt for food manufacturers and
consumers.
MicroSalt is a major potential
disruptor in the food market, thanks to its micron sized particles
which deliver the same sense of saltiness to a wide range of foods
but with approximately 50% less sodium. Excess sodium consumption
is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier
alternatives to traditional salt. The WHO
has set a target for reducing global sodium intake by 30% by 2025,
which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease
costs the UK £19 billion - if the average salt intake was reduced
by one gram per day, it has been estimated that 4,147 lives and
£288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70 per
cent. of the typical person's sodium intake is hidden in processed
foods.
Operational since 2018, MicroSalt
uses a patent-protected technology which helps create high barriers
to entry within the reduced-sodium salt market. The group has a US
patent and 14 patent applications pending in other jurisdictions
globally.
The Directors believe that MicroSalt
is well positioned to capture growth in the low sodium market,
which is expected to grow exponentially, and that there is also
scope to enter the larger salt market.
MicroSalt has a three-pronged
marketing strategy, targeting large B2B food manufacturers, the B2C
market and e-commerce customers. Microsalt's all natural,
low-sodium solution is well positioned to take advantage of the
fast-growing market for a healthier alternative to traditional
salt.
ENDS